• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Comprehensive Overview of 2-(Difluoromethoxy)benzeneboronic acid (CAS No. 947533-11-1)

2-(Difluoromethoxy)benzeneboronic acid (CAS No. 947533-11-1) is a specialized boronic acid derivative widely utilized in pharmaceutical research, organic synthesis, and material science. This compound features a difluoromethoxy group attached to a benzene ring, which enhances its reactivity and stability in cross-coupling reactions, particularly Suzuki-Miyaura coupling. Its unique structure makes it a valuable intermediate for developing biologically active molecules and advanced materials.

The growing demand for fluorinated boronic acids like 2-(Difluoromethoxy)benzeneboronic acid is driven by their applications in drug discovery and agrochemical development. Researchers are increasingly exploring its potential in designing kinase inhibitors and anticancer agents, aligning with trends in precision medicine. The compound's electron-withdrawing properties due to the difluoromethoxy moiety also improve its performance in catalytic processes, making it a topic of interest in green chemistry discussions.

In the context of AI-driven drug design, 947533-11-1 has gained attention as a building block for high-throughput screening libraries. Its compatibility with automated synthesis platforms and machine learning-based property prediction tools positions it as a key player in digital chemistry workflows. Recent publications highlight its role in optimizing ADMET profiles (Absorption, Distribution, Metabolism, Excretion, and Toxicity) of lead compounds.

The compound's thermal stability and solubility characteristics make it suitable for OLED materials and organic electronics applications. With the rise of flexible electronics and wearable sensors, 2-(Difluoromethoxy)benzeneboronic acid is being investigated for its potential in creating conductive polymers with enhanced environmental resistance.

From a synthetic chemistry perspective, this benzeneboronic acid derivative demonstrates remarkable regioselectivity in palladium-catalyzed reactions. Its ortho-substitution pattern influences reaction kinetics, a subject frequently discussed in mechanistic studies and catalysis forums. The compound's crystalline form has been characterized by X-ray diffraction, providing structural insights valuable for computational chemistry modeling.

Environmental considerations surrounding fluorinated compounds have prompted studies on the biodegradability of 947533-11-1. While showing moderate persistence, its low bioaccumulation potential makes it preferable to heavier halogenated analogs in sustainable chemistry applications. This aligns with the pharmaceutical industry's focus on greener synthetic routes and PFAS alternatives.

The analytical characterization of 2-(Difluoromethoxy)benzeneboronic acid typically involves HPLC purity analysis, 19F NMR spectroscopy, and mass spectrometry. These techniques confirm the compound's structural integrity and chemical purity, critical parameters for quality control in commercial batches. Recent advancements in benchtop NMR technology have simplified its characterization in small-scale research settings.

Supply chain dynamics for boronic acid reagents have evolved with increasing custom synthesis options and just-in-time manufacturing approaches. The availability of 947533-11-1 in various packaging formats, from milligram-scale vials to kilogram quantities, supports diverse research needs while minimizing chemical waste through portion-controlled distribution.

Emerging applications in bioconjugation chemistry exploit the compound's ability to form stable boronate esters with diols. This property is being harnessed in diagnostic probe development and targeted drug delivery systems, particularly for glycan recognition in cancer biomarkers detection. The difluoromethoxy group contributes to improved metabolic stability in these biomedical applications.

From a regulatory standpoint, 2-(Difluoromethoxy)benzeneboronic acid is classified as non-hazardous under standard laboratory handling conditions. Its material safety data sheet (MSDS) indicates typical precautions for boron-containing compounds, with emphasis on proper ventilation and personal protective equipment during manipulation. The compound's low volatility reduces inhalation risks compared to more small-molecule reagents.

In the educational sphere, this compound serves as an excellent example for teaching organoboron chemistry principles. Its synthesis demonstrates key concepts in electrophilic aromatic substitution and protodeboronation mechanisms, making it relevant for advanced organic chemistry curricula. The growing interest in handson synthetic training has increased its use in university research labs worldwide.

The commercial landscape for 947533-11-1 features competitive pricing among fine chemical suppliers, with purity grades ranging from 95% technical grade to 99.9% ultra-pure for sensitive applications. Recent market analyses show steady growth in demand, particularly from contract research organizations (CROs) and biotech startups focusing on novel therapeutic modalities.

Looking forward, the development of continuous flow methods for producing 2-(Difluoromethoxy)benzeneboronic acid may further enhance its accessibility. Process chemistry innovations aim to reduce heavy metal catalysts usage while maintaining high atom economy - key objectives in modern pharmaceutical manufacturing sustainability initiatives.

• 175676-65-0(o-(Trifluoromethoxy)phenylboronic Acid)
• 688810-12-0([4-(difluoromethoxy)phenyl]boronic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)